51817-0586 Bortezomib

Product NDC:

51817-0586

Brand Name:

Bortezomib

Generic Name:

Bortezomib

Dosage Form Name:

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Administration Route:

Intravenous

Subcutaneous

Substances:

Name: BORTEZOMIB

Strength: 3.5

Unit: mg/1

Packages:

Code: 51817-0586-01

Description: 1 VIAL in 1 CARTON (51817-586-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

Effective Date: May 2, 2022

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Proteasome Inhibitor

Minor Class:

26S

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox